ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group

February 28, 1997

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

In Brief: Bast To Head M.D. Anderson Medicine Dib.; Ozer Named Emory Cancer Center Director

April 8, 1994

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991

NCI, NIH Hoping 12 Percent Budget Cut Will Not Be Applied To Them

October 2, 1981

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994